Eingeschlossene Patienten: 23.123 (Stand 01. November 2024)
Amgevita® (Adalimumab)
232
Benepali® (Etanercept)
1231
Cimzia® (Certolizumab)
1038
Enbrel® (Etanercept)
2872
Erelzi® (Etanercept)
566
Flixabi® (Infliximab)
10
Hukyndra® (Adalimumab)
8
Hulio® (Adalimumab)
258
Humira® (Adalimumab)
2910
Hyrimoz® (Adalimumab)
239
Idacio® (Adalimumab)
66
Imraldi® (Adalimumab)
230
Inflectra™ (Infliximab)
17
Jyseleca® (Filgotinib)
153
Kevzara® (Sarilumab)
223
Kineret® (Anakinra)
89
MabThera® (Rituximab)
1459
Nepexto® (Etanercept)
90
Olumiant® (Baricitinib)
545
Orencia® (Abatacept)
990
Remicade® (Infliximab)
762
Remsima® (Infliximab)
25
Rinvoq® (Upadacitinib)
311
Rixathon® (Rituximab)
20
RoActemra® (Tocilizumab)
1378
Ruxience® (Rituximab)
1
Simponi® (Golimumab)
473
Truxima® (Rituximab)
2
Tyenne® (Tocilizumab)
31
Xeljanz® (Tofacitinib)
397
Yuflyma® (Adalimumab)
46
Zessly® (Infliximab)
2
Kontrollen
6449
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok